Aurobindo Pharma consolidated net profit declines 10.28% in the June 2025 quarter
(05 Aug 2025)

Back
Net profit of Aurobindo Pharma declined 10.28% to Rs 824.75 crore in the quarter ended June 2025 as against Rs 919.22 crore during the previous quarter ended June 2024. Sales rose 4.48% to Rs 7791.77 crore in the quarter ended June 2025 as against Rs 7457.65 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales7791.777457.65 4
OPM %20.5721.70 -
PBDT1612.501728.07 -7
PBT1206.801323.89 -9
NP824.75919.22 -10

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew